CLINICAL_TRIALS
trial_result
· 2023-07-19
Clinical Trial Update: Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs [Phase 1, Phase 2]
Summary
Phase 1/Phase 2 trial evaluating safety and preliminary efficacy of 177Lu-OPS201 in neuroendocrine tumors was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Neuroendocrine Tumors | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-07-19